Guangdong International Raw Material Center Invites Worldwide Investment
This article was originally published in PharmAsia News
Executive Summary
The International Raw Material Center of Health Industry, China's largest health industry raw material distribution center based in Zhuhai, Guangdong province, has opened its doors to worldwide investment. The invitation represents an unprecedented one for the local health industry in terms of construction scale and investment scope, which cover almost all health-related fields. Observers believe that the development of a health cluster will help the industry secure high-end business and establish China in the global market. (Click here for more)
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.